Correlation Between Auxly Cannabis and Cannara Biotech

Can any of the company-specific risk be diversified away by investing in both Auxly Cannabis and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Auxly Cannabis and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Auxly Cannabis Group and Cannara Biotech, you can compare the effects of market volatilities on Auxly Cannabis and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Auxly Cannabis with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Auxly Cannabis and Cannara Biotech.

Diversification Opportunities for Auxly Cannabis and Cannara Biotech

-0.15

Correlation Coefficient

Auxly Cannabis  Cannara Biotech

Good diversification

The 3 months correlation between Auxly and Cannara is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Auxly Cannabis Group and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Auxly Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Auxly Cannabis Group are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Auxly Cannabis i.e., Auxly Cannabis and Cannara Biotech go up and down completely randomly.

Pair Corralation between Auxly Cannabis and Cannara Biotech

Assuming the 90 days trading horizon Auxly Cannabis Group is expected to generate 3.28 times more return on investment than Cannara Biotech. However, Auxly Cannabis is 3.28 times more volatile than Cannara Biotech. It trades about 0.08 of its potential returns per unit of risk. Cannara Biotech is currently generating about 0.01 per unit of risk. If you would invest  1.50  in Auxly Cannabis Group on October 1, 2024 and sell it today you would earn a total of  2.00  from holding Auxly Cannabis Group or generate 133.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Auxly Cannabis Group  vs.  Cannara Biotech

Auxly Cannabis Group

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Auxly Cannabis Group are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Auxly Cannabis displayed solid returns over the last few months and may actually be approaching a breakup point.

Cannara Biotech

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Auxly Cannabis and Cannara Biotech

The main advantage of trading using opposite Auxly Cannabis and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Auxly Cannabis position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.

The idea behind Auxly Cannabis Group and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.